Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-19T16:16:31.179Z Has data issue: false hasContentIssue false

7 - Therapeutic decision making in BMT/SCT for non-Hodgkin lymphoma

Published online by Cambridge University Press:  31 July 2009

Reinhold Munker ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University
Hillard M. Lazarus
Affiliation:
University Hospitals Case Medical Center
Kerry Atkinson
Affiliation:
University of Queensland
Get access
Type
Chapter
Information
The BMT Data Book , pp. 99 - 126
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Armitage, JO, Vose, JM, Linder, J, et al., 1989. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 7: 1783–90.CrossRefGoogle ScholarPubMed
Barosi, G, Carella, A, Lazzarino, M, et al., 2005. Management of nodal indolent (non-marginal zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow TransplantationHaematologica 90: 1236–57.Google Scholar
Barosi, G, Carella, A, Lazzarino, M, et al., 2006. Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow TransplantationHaematologica 91: 96–103.Google Scholar
Behler, CM, Kaplan, LD. 2006. Advances in the management of HIV-related non-Hodgkin lymphomaCurr Opin Oncol 18: 437–43.CrossRefGoogle ScholarPubMed
Brown, JR, Yeckes, H, Friedberg, JW, et al., 2005. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 23: 2208–14.CrossRefGoogle ScholarPubMed
Carbone, PP, Kaplan, HS, Musshoff, K, et al., 1971. Report of the committee on Hodgkin's disease staging classification. Cancer Res 31: 1860–61.Google Scholar
Coiffier, B, Lepage, E, Brière, J, et al., 2002. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235–42.CrossRefGoogle ScholarPubMed
Corradini, P, Ladetto, M, Zallio, F, et al., 2004. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: Evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. J Clin Oncol 22: 1460–68.CrossRefGoogle ScholarPubMed
Dave, SS, Fu, K, Wright, GW, et al., 2006. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354: 2431–42.CrossRefGoogle ScholarPubMed
Dreyling, M, Lenz, G, Hoster, E, et al., 2005. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL network. Blood 105: 2677–84.CrossRefGoogle ScholarPubMed
Fernandez, HF, Escalón, MP, Pereira, D, Lazarus, HM. 2007. Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road?Bone Marr Transpl 40: 505–13.CrossRefGoogle ScholarPubMed
Freytes, CO, Loberiza, FR, Rizzo, JD, et al., 2004. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. Blood 104: 3797–803.CrossRefGoogle ScholarPubMed
Hennessy, BT, Hanrahan, EO, and Daly, PA. 2004. Non-Hodgkin lymphoma: an update. Lancet Oncol 5: 341–53.CrossRefGoogle ScholarPubMed
,International Non-Hodgkin's Lymphoma Prognostic Factors Project. 1993. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987–94.CrossRefGoogle Scholar
Kasamon, YL. 2007. Blood or marrow transplantation for mantle cell lymphoma. Curr Op Oncol 19: 128–35.CrossRefGoogle ScholarPubMed
Krishnan, A, Zaia, J, and Forman, SJ. 2003. Should HIV-positive patients with lymphoma be offered stem cell transplants?Bone Marr Transpl 32: 741–48.CrossRefGoogle ScholarPubMed
Milpied, N, Deconinck, E, Gaillard, F, et al., Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem cell-cell support. N Engl J Med 350: 1287–95.CrossRef
Mollee, P, Lazarus, HM, and Lipton, J. 2003. Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?Bone Marr Transpl 31: 953–60.CrossRefGoogle ScholarPubMed
Munker, R, Hiller, E, Glass, J, Paquette, R (Eds). 2007. Modern Hematology, Totowa, NJ: Humana Press.CrossRef
Peggs, KS, Mackinnon, S, and Linch, DC. 2004. The role of allogeneic transplantation in non-Hodgkin's lymphomaBr J Haematol 128: 153–68.CrossRefGoogle Scholar
Pfreundschuh, M, Trümper, L, Österborg, A, et al., 2006. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial Group. Lancet Oncol 7: 379–91.CrossRefGoogle Scholar
Philip, T, Guglielmi, C, Hagenbeek, A, et al., 1995. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333: 1540–45.CrossRefGoogle ScholarPubMed
Rohatiner, AZS, Nadler, L, Davies, AJ, et al., 2007. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol 18: 2554–59.CrossRefGoogle Scholar
Romaguera, JE, Fayad, L, Rodriguez, MA, et al., 2005. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol 28: 7013–23.CrossRefGoogle Scholar
Sehn, LH, Berry, B, Chhanabhai, M, et al., 2007. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. Blood 109: 1857–61.CrossRefGoogle Scholar
Solal-Céligny, P, Roy, P, Colombat, P, et al., 2004. Follicular lymphoma international prognostic index. Blood 104: 1258–65.CrossRefGoogle ScholarPubMed
Stone, RM (1994) Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress?Blood 83: 3437–40.Google Scholar
Svoboda, J, Andreadis, C, Elstrom, R, et al., 2006. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marr Transpl 38: 211–16.CrossRefGoogle ScholarPubMed
Tarella, C, Gianni, AM. 2005. Bone marrow transplantation for lymphoma CR1. Curr Op Oncol 17: 99–105.CrossRefGoogle ScholarPubMed
Besien, K. 2006. The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphomaBlood Rev 20: 235–44.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×